vTv Therapeutics executes 1-for-40 reverse stock split to regain Nasdaq $1.00 minimum bid compliance

vTv Therapeutics Inc.

Reverse split at 1-for-40 ratio became effective at 4:01 p.m. ET on November 20, 2023.
Purpose is to regain compliance with Nasdaq's $1.00 minimum closing price for continued listing.
Fractional shares resulting from the split are rounded up to the nearest whole share.
Percentage ownership unchanged for each stockholder except for fractional share adjustments.
Class A common stock continues trading under symbol VTVT with new CUSIP 91835204.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.